Wireless Cardiac Stimulation
Total Trials
9
As Lead Sponsor
6
As Collaborator
3
Total Enrollment
879
NCT01294527
Wireless Stimulation Endocardially for Cardiac Resynchronization Therapy
Phase: N/A
Role: Lead Sponsor
Start: Feb 28, 2011
Completion: Oct 31, 2016
NCT02038972
Safety of Autologous Stem Cell Infusion for Children With Acquired Hearing Loss
Phase: Phase 1/2
Role: Collaborator
Start: Jan 31, 2013
Completion: Jan 10, 2017
NCT01905670
Safety and Performance of Electrodes Implanted in the Left Ventricle
Start: Jul 31, 2013
Completion: Nov 30, 2019
NCT02610673
WiCS-LV Post Market Surveillance Registry
Start: Feb 8, 2016
Completion: Jun 30, 2027
NCT02922036
Cardiac Resynchronization Therapy in Previously Untreatable and High Risk Upgrade Patients
Start: Jan 17, 2018
Completion: Jun 30, 2026
NCT06156241
Stem Cell Study for Long COVID-19 Neurological Symptoms
Phase: Phase 1
Start: Jan 31, 2024
Completion: Feb 28, 2026
NCT05451797
Implant of the WiSE CRT System With an Intracardiac Pacemaker
Start: Jul 1, 2024
Completion: Dec 31, 2025
NCT07098858
The WiSE®-UP Registry (The WiSE System Utilization & Performance Registry)
Start: Sep 1, 2025
Completion: Sep 30, 2032
NCT06561932
A Feasibility Study Implant of the WiSE® CRT System With an Intracardiac Pacemaker to Achieve Totally Leadless CRT
Start: Oct 1, 2025
Completion: Apr 1, 2026
Loading map...